Novavax becomes 5th approved vaccine of Covid-19 in Australia

Novavax's COVID-19 vaccine, a vaccine that protects against the virus, became the fifth vaccine approved for use in Australia.

Currently, around 51 million doses of the U.S. manufactured vaccine, which are supplied under the brand Nuvaxovid, has been ordered by the country for the population of 26 million. Already AstraZeneca, Moderna, and Pfizer vaccines are being used in the country. However, the Janssen vaccine from Johnson and Johnson is also approved in Australia, but the government has not purchased it yet.

The Novavax vaccine will be offered to the unvaccinated citizens of Australia aged 18 years and above but will not be used as a booster dose for 95% of the population aged 16 and above who have already received a vaccine.

However, there are still many individuals who are now waiting to take up vaccination in the country, who have been especially waiting for Novavax to be approved. And, it is good news that the vaccine has received a go-ahead, said Chief Regulator John Skerritt, Head of the Therapeutic Goods Administration.

He further said that the country might turn its decision of 95% to 97 or 98%.

Moreover, the vaccine, based on protein, is to be executed in two doses within three weeks.

Paul Griffin, Associate Professor of Medicine at Queensland University mentioned that Australia requires to put its whole effort into improving the already inspiring vaccination rate.

For many reasons, it appears to be as some people have been unenthusiastic or keen for receiving these vaccines so far. That is why an additional option based on what is said to be a more traditional platform will probably increase the vaccination rate further, said Griffin.

Moreover, Novavax demonstrated an efficacy of 96% in preventing the COVID-19 infection in its initial trials in March 2021. But the firm battled for months for manufacturing and regulatory delays in 2021.

Notably, Indonesia became the first country to approve the drug last November.

Source Credit - https://www.business-standard.com/article/international/australia-greenlights-novavax-coronavirus-vaccine-fifth-in-nation-122012000300_1.html